相关实验视频

Updated: Jan 13, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

在从食道到结肠的eosinophilic肠道疾病中针对粘膜eosinophils的治疗方法

Khaliun Batkhurel^1,2, Sharmila Prasad¹, Michael Potter^1,2

¹NHMRC Centre of Research Excellence in Transforming Gut Health, University of Newcastle, Newcastle, New South Wales, Australia.

Journal of gastroenterology and hepatology

|January 9, 2026

概括

埃索诺菲尔性胃肠道疾病 (EGIDs) 正在增加,并且可能被诊断不足. 虽然疗法减少了乙氨基,但症状缓解有所不同,这表明超出乙氨基之外的复杂疾病途径.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

异性胃肠道疾病 (EGIDs),包括异性食管炎 (EoE) 和非EoE EGIDs,越来越普遍,并且可能被诊断不足.
虽然EoE的死亡率正常,但其他EGID的死亡风险增加. 在功能性消化不良等疾病中也注意到埃索诺菲尔的增加.
病原发生涉及氨基酸透,但治疗的可变症状反应表明非氨基酸通路也很重要.

研究的目的:

审查目前对EGID的理解和管理.
突出EGIDs的治疗策略和正在进行的研究.
讨论埃索诺菲尔和其他途径在EGID病变发生过程中的作用.

主要方法:

对EGID流行,诊断和治疗的现有文献的综述.
对EoE和非EoE EGIDs当前标准疗法的分析.
新兴药理学标和试验疗法的概述.

主要成果:

标准的EoE疗法包括PPI,局部皮质类固醇,饮食和dupilumab.
非EoE EGID的治疗通常涉及饮食,皮质类固醇或免疫调节剂;随机试验的数据有限.
向治疗可以减少乙酸的透,但症状反应不一致.

结论:

EGIDs代表了胃肠道学日益关注的领域,其复杂的病理生理学.
目前对EoE的治疗方法已经确立,而非EoE EGID的治疗方法在可靠的临床试验数据中不那么明确.
未来的研究重点是针对特定炎症途径的新型药物治疗,以及改善症状管理.

关键词:

对于EGDI治疗方法欧洲旅游服务中心 (EGDI)埃索诺菲尔性肠道疾病是什么?埃索诺菲尔细胞的存在

更多相关视频

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

相关概念视频

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...